Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly! All these chart readers with "correction coming" have one agenda: to kick themselves for selling too soon and hope to buy at lower prices...lol
All, just relax, the fact TSRX is north of 10.5 speaks for awesome strength and steady accumulation that's going on at these levels. Big boys are loading up and any weak hands already left the barn...
Though the company has said 2H13, they will file in 3Q (by Sept) or latest by October to avoid hols
Agree. I see $12 to $14 range near term prior to NDA filing. Upon filing news, I expect few more points north of $15.
It cannot be just fluke that so many patients who are on ICT-107 trial have reported no recurrence of tumors albeit after surgery as SOC. For any surgery options, there is always a trace of rogue cells and after 8 t0 10 MRI's no signs of tumor means something is happening...
IMUC is definitely getting lot of attention on two counts:
1. CLDX run-up based on their immunotherapy for Brian & Breast cancers
2. ICT-107 trial patients website continue to eschew good indicators for promising results potential similar to PI.
If PII results are anywhere close to what we have seen in single arm PI, $20 to $30 pps is not out of question.
IMUC could very well become SRPT
$1 Billion market is very doable for Trius. TED has all the efficacy sans terrible nerve damaging long term side effects.
The bounce back today was awesome
Great interview on Cramer's show last night. More possibility of additional analyst upgrades especially with JPM presentation.
With OPTR trading around $15 per share, I expect TSRX to rally up to these levels prior to approval or may be even more by end of this year, partnership news notwithstanding. That will be an icing on the cake.
$20 by early 2014 for sure...
EOY or latest early '14..but there will be other news will make the pps move
Any insider buys will trigger upward movement. PPS is lowest now that it can get. Other indicator to watch is for Institutional buys..it's at 13%/49 It will be interesting to see Q2 data in few weeks.
If overall market continues to be good, we can start seeing rally by end of 3Q or latest beginning of 4Q. if PII is +ve, we will open like 10+ points gap..just look at CLDX..
All longs...
A MUST READ
http://aheadofcancer.com/ict-107-clinical-trial-update/
Just look at the Quick Facts section on this guy's website..
ENROLLED and PAST 8 MRI's SHOW NO SIGNS OF TUMOR !!!!
Now you decide whether you want to back up your truck to load IMUC or not
Press conference ? It's JP Morgan presentation...if we get some specific information on NDA timing, we would be off to races..Euro partnership updates are possible as well. Regardless an upbeat presentation is all I am expecting,
You just posted his comments half-way. He also said, approval of Tedzoid is very high and he would be a buyer on any pullback. When you report, report fully
I wonder why insiders are not loading up at these prices. Will be interesting to see if institutions holding has changed q to q.
You are right on the money
Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains
TSRX is on this list
http://247wallst.com/2013/06/13/merrill-lynch-top-biotechnology-stocks-to-buy-for-big-gains/
It is not a dump pre planned company program
Tedz is a Zyvox killer..see below:
http://www.fda.gov/drugs/drugsafety/ucm265305.htm
Smith is a garbage..no real dd, just rehash on known public news. I am watching for funds % closely and any further uptick would be a strong signal (10.98% jump from prior to latest qtr is good).
Insider buys would help as well..holding core shares (30k) and watching
We will see $20 by year end. The next milestone is Euro partnership. Good chance for a buyout as well. $TSRX will do $ACAD, mark this post, my fellow longs
I think an analyst report will be out soon. The remarkable news today is both safety issues and futility is ruled out now ! Futility was the biggest risk. Expecting upgrades
Is it now resonable to expect Reasonable to reason with reality which is TSRX is on uptrend ? But we all know the answer..lol
You really crack me up. all these highs and low-balling the exit & entry timing is useless for long term investors. If you are a trader, SRPT may be a better stock. You get almost a $1 swing each day. Coming to the point, TSRX is under accumulation. Any dips will be bought and unless the whole market corrects, we won't see low 7's again..
7.82 and climbing...lol.. all who waited to save few pennies can continue to dream on
Great news for Cancer Immunotherapy companies such as IMUC
http://www.reuters.com/article/2013/05/22/cancer-immunotherapy-idUSL6N0E30PN20130522?feedType=RSS&feedName=basicMaterialsSector&rpc=43
I doubt this time as the institutions have been buying now. With PT of $20, the pps will go up to hit the $8.50 short term. The NDA filing is few months away and with fully de-risked, I don't think any retail investors will sell now let alone the institutions.
This is what exactly I expected (consolidation around $8 area). It will at minimum jump few points upon FDA filing next few months. Good chance of EU partnership as well.
Certainly I sold all mine and won't post any further until INO announces partnership or some significant +ve news. I rather buy higher than waste years of unprofitable investment. Meanwhile good luck to all.
I used to share your enthusiasm especially after upbeat comments by Dr. Kim at RetailInvestorsConference event in feb. Dr. Kim gave all out promise of impending partnerships and how he dislikes dilution etc. The slides are still available. And what did we get ? Secondary below market price soon after and a 'proxy' failure from chrontech that Innovio failed to handle properly with all their stellar BOD crew.
The red flag currently is lack of institutional investment (other than few Hedgies who got in below market and with fat warrants) and how they botched especially the PR on chrontech vaccine failure. Why would Innovio own up the news release when it was not their vaccine ?
With regard to R/S, actually it might prove to be the right step for Dr. Kim to prop up the price significantly if no partnerships with sizable investment happens soon. 600 Million auth is one step towards that direction. He has a long hurdle to prove that his platform outweighs Novartis's $1 Billon vaccine plant and its adjuvant based approach.
Dr. Kim and his flue vaccines is going to take very long time to be a viable commercial product. Market knows this.
Recent increase on shares count to 600 Million has spooked the investors. With the current market conditions I won't be surprised if we visit 0.50 again...
While I cannot predict when, RS is coming for sure. No funds will get in with 600 Million authorized shares. If RS happens, INO has a healthier chance of getting out of penny stock rut at the cost of current shareholders.
IMUC will nicely jump once the DMC recommends a simple continue..which alone greatly de-risks any safety issues. It's very unlikely DMC will stop the trial because of futility as we have big margin on efficacy based on PI trial albeit with no placebo (even a few months of survival is a great news).
Dr. Kim is a great manipulator of retail investors' mind. He pumped the company in another conference prior to placing the secondary, when the pps briefly hit the highs due to his savy talk. He then sold the soul to only sell shares cheaper than market. He is doibg this act again.
With 170 Million OS and climbing, RS is on the cards. Where are the Maxim and Piper jokers who set the price target ? I bet they helped their HF buddies on the secondary.
Disclaimer: I was long until the secondary was placed and currently have no position.
Points well taken. While things including partnerships could still happen, the red herring to be was the pricing of recent secondary. The stock never rallied to $1 buck after Piper upgrade as well as Maxim's. Meanwhile Dr. Kim is shoveling more cheap shares into the hands of HF especially after he clearly said (the presentation is still available) that this would be the last resort and he very much expect partnerships to happen in 'next few months'. Well we are into Q2 but the way company handled Chrontech fiasco is mind blowing. Lower doses ? WHy squander away meagre funds ( I believe INO providing some funding to Chrontech) only to see a failure ? Also Kim is stitting on a pile of a moountain of shares and he could easily enact a private placement of this huge portion to other serious investors without diluting further.
Bottom line is, us, the retail investors are holding this iron boat still.
Dr. KIm buying today means squat, IMHO. He squandered the good will with his below market secondary recently.
Also newbies do not know the history of INO nor the fact that it's typical for such penny biotechs to reverse-split only to screw the current shareholders.
While I have not sold my position (not significant though), I will wait for the reverse split to add more.
PT raised to $45 by Leer this morning. Great !
ZIOP AF is positive on this... a skeptic to the core..lol
Awesome ! This remainds me of the trade I hit the paydirt on. The stock was SRPT that jumped from $14+ to $40 overnight when their PI results came out positive for DMD.
400 chips at $550 is lot of moola for Day Trade allowance
Another case in example is CLDX..
LOl..if all goes well, he will be soon jumping over the Mars
Yep. Dr. Kim is firing on all cylinders. It's just that more patience is reqd. One thing of late, I noted is Dr Kim is attending all important conferences.